News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
VENROCK ASSOCIATES IV L P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/28/2019 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Sold 704,595 shares
@ $0.5015, valued at
$353.4k
Sold 56,242 shares
@ $0.4536, valued at
$25.5k
Sold 333,010 shares
@ $0.4387, valued at
$146.1k
|
|
| 10/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2019 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 142,857 shares
@ $0.7, valued at
$100k
|
|
| 03/14/2019 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 142,857 shares
@ $0.7, valued at
$100k
|
|
| 09/17/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 75,000 shares
@ $1.1888, valued at
$89.2k
Bought 75,000 shares
@ $1.23, valued at
$92.3k
Bought 60,000 shares
@ $1.1824, valued at
$70.9k
|
|
| 09/17/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 75,000 shares
@ $1.1888, valued at
$89.2k
Bought 75,000 shares
@ $1.23, valued at
$92.3k
Bought 60,000 shares
@ $1.1824, valued at
$70.9k
|
|
| 09/12/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 200,000 shares
@ $1.2182, valued at
$243.6k
Bought 200,000 shares
@ $1.1442, valued at
$228.8k
Bought 75,000 shares
@ $1.1455, valued at
$85.9k
|
|
| 09/12/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 200,000 shares
@ $1.2182, valued at
$243.6k
Bought 200,000 shares
@ $1.1442, valued at
$228.8k
Bought 75,000 shares
@ $1.1455, valued at
$85.9k
|
|
| 09/07/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.8465, valued at
$42.3k
Bought 50,000 shares
@ $0.8419, valued at
$42.1k
Bought 60,000 shares
@ $0.8957, valued at
$53.7k
|
|
| 09/07/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.8465, valued at
$42.3k
Bought 50,000 shares
@ $0.8419, valued at
$42.1k
Bought 60,000 shares
@ $0.8957, valued at
$53.7k
|
|
| 08/16/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 190,977 shares
@ $0.6486, valued at
$123.9k
Bought 272,000 shares
@ $0.6467, valued at
$175.9k
Bought 66,393 shares
@ $0.6493, valued at
$43.1k
|
|
| 08/16/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 190,977 shares
@ $0.6486, valued at
$123.9k
Bought 272,000 shares
@ $0.6467, valued at
$175.9k
Bought 66,393 shares
@ $0.6493, valued at
$43.1k
|
|
| 11/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/17/2014 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Achaogen Inc|
Txns:
| Converted 340,797 shares
@ $0
Converted 296,878 shares
@ $0
Converted 725,873 shares
@ $0
Converted 382,913 shares
@ $0
Converted 296,981 preferred shares
@ $0
Converted 223,440 preferred shares
@ $0
Converted 725,873 preferred shares
@ $0
Converted 382,913 preferred shares
@ $0 |
|
| 11/19/2013 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Sold 150,000 shares
@ $14.06, valued at
$2.1M
|
|
| 09/24/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Sold 19,273 shares
@ $6.3019, valued at
$121.5k
|
|
| 09/18/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Sold 35,000 shares
@ $6.5087, valued at
$227.8k
|
|
| 09/13/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Sold 10,177 shares
@ $6.6427, valued at
$67.6k
Sold 15,000 shares
@ $6.5553, valued at
$98.3k
|
|
| 07/05/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Disposed of 900,000 shares
@ $0
Acquired 79,450 shares
@ $0 |
|
| 05/10/2011 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Disposed of 850,000 shares
@ $0
Acquired 11,293 shares
@ $0 |
|
| 12/02/2010 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Converted 1,752,808 shares
@ $0
Converted 133,622 shares
@ $0
Converted 139,105 shares
@ $0
Bought 600,000 shares
@ $5, valued at
$3M
Converted 1,752,808 convertible preferred
@ $0
Converted 133,622 convertible preferred
@ $0
Converted 139,105 convertible preferred
@ $0 |
|
| 04/28/2010 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Converted 2,243,732 shares
@ $0
Converted 934,110 shares
@ $0
Converted 465,157 shares
@ $0
Bought 306,071 shares
@ $11, valued at
$3.4M
Converted 2,243,732 convertible preferred
@ $0
Converted 934,110 convertible preferred
@ $0
Converted 465,157 convertible preferred
@ $0 |
|
|
|